ENHERTU® (fam-trastuzumab | deruxtecan-nxki) - HCP Site
SponsoredPhysicians: ENHERTU Is Now Approved In A New Indication. View The PI & Boxed Warnings. Visit The Physician Site To See Efficacy & Safety Data From A New Clinical Trial.ENHERTU® (fam-trastuzumab | deruxtecan-nxki) Patient Site
SponsoredVisit Patient & Care Partner Site To Learn About ENHERTU. View The PI & Boxed Warnings. View Downloadable Patient Brochures For ENHERTU®.Service catalog: Doctor Discussion Guide, Sign Up For Updates, Patient Resources
Related Products
Some results have been hidden because they may be inaccessible to you.Show inaccessible results
HER2+ Metastatic Breast Cancer | Treatment Info For Physicians
SponsoredHCPs - Visit To Learn More About A Treatment Option For 2L HER2+ Metastatic Breast Cancer. Find Access Information & Additional Resources For Your Patients.2L HER2+ mBC Treatment · Access Information · Register For Updates · Physician Website
Service catalog: Professional Resources, Downloadable Resources, Safety InfoHER2+ eBC Treatment Info | Treatment Info For Patients
SponsoredPatients - Familiarize Yourself With The HER2+ Early Breast Cancer Treatment Experience. Answer A Few Questions To Find Information About Some Treatment Options For HER2+ eBC.Questions For Your Doctor · Download Discussion Guide · HER2+ eBC Resources
Types: Diagnosis, Neoadjuvant Treatment, Surgery, Adjuvant TreatmentLearn More About Tivdak® | (tisotumab vedotin-tftv)
SponsoredFor Injection 40 Mg. View Safety And Prescribing Info Including Boxed Warning For Tivdak. I Have More To Say. Patients Speak To Your Physician & Learn About Tivdak Today.